# OnCo record til-therapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/til-therapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "til-therapy" ;
  schema:name "TIL therapy"@en ;
  schema:description "Immune cells that have already found their way into the tumour are harvested, grown to billions, and returned."@en ;
  schema:url <https://onco.cc/technologies/til-therapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tumor-infiltrating_lymphocytes> ;
  owl:sameAs <http://www.wikidata.org/entity/Q7852668> ;
  schema:citation <https://en.wikipedia.org/wiki/Tumor-infiltrating_lymphocytes>, <https://doi.org/10.1158/1078-0432.ccr-13-0380> ;
  onco:status "approved" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lifileucel/> ;
  onco:companies <https://onco.cc/companies/iovance/>, <https://onco.cc/companies/obsidian-therapeutics/>, <https://onco.cc/companies/turnstone-biologics/> ;
  onco:institutions <https://onco.cc/institutions/sheba/> ;
  onco:people <https://onco.cc/people/michal-besser/>, <https://onco.cc/people/jacob-schachter/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-besser-til-melanoma-intent-to-treat-ccr-2013/> ;
  onco:dependsOn <https://onco.cc/technologies/cell-therapy-cold-chain/>, <https://onco.cc/technologies/cell-therapy-release-testing/>, <https://onco.cc/technologies/cytokine-therapy/> .